- Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model
-
Akdemir A, Zeybek B, Akman L, Ergenoglu , Yeniel AO, Erbas O, Yavasoglu , Terek MC, Taskiran D
- KMID: 2130122
- J Gynecol Oncol.
- 2014 Oct;25(4):328-333.
- doi: 10.3802/jgo.2014.25.4.328
OBJECTIVE: To investigate whether granulocyte-colony stimulating factor (G-CSF) can decrease the extent of ovarian follicle loss caused by cisplatin treatment. METHODS: Twenty-one adult female Sprague-Dawley rats were used. Fourteen rats were... -
- CITED
-
- Close
- SHARE
-
- Close
- Granulocyte Colony Stimulating Factor Attenuates Hyperoxia-Induced Lung Injury by Down-Modulating Inflammatory Responses in Neonatal Rats
-
Jeon GW, Sung DK, Jung YJ, Koo SH, Choi SH, Chang YS, Sin JB, Park WS
- KMID: 1106439
- Yonsei Med J.
- 2011 Jan;52(1):65-73.
- doi: 10.3349/ymj.2011.52.1.65
PURPOSE: Granulocyte colony stimulating factor (G-CSF) has been known to increase neutrophil production and have anti-inflammatory properties, but the effect of G-CSF on pulmonary system is in controversy. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
-
Lee SR, Yang DH, Ahn JS, Kim YK, Lee JJ, Choi YJ, Shin HJ, Chung JS, Cho YY, Chae YS, Kim JG, Sohn SK, Kim HJ
- KMID: 1779170
- J Korean Med Sci.
- 2009 Jun;24(3):498-503.
- doi: 10.3346/jkms.2009.24.3.498
A refractory and resistant disease to conventional induction chemotherapy and relapsed disease are considered as the most important adverse prognostic factors for acute myeloid leukemia (AML). Sixty-one patients (median age,... -
- CITED
-
- Close
- SHARE
-
- Close
